News
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
Novavax, Inc. (Nasdaq: NVAX) today announced preliminary results from the SHIELD-Utah study (Study of Healthcare Workers and ...
Novavax (NasdaqGS:NVAX) recently announced promising preliminary results from the SHIELD-Utah study, which highlighted fewer and less severe reactogenicity symptoms for its COVID-19 Vaccine, ...
Workers who received Novavax reported 12.5% fewer local reactions than those who received the Pfizer vaccine. Average hours ...
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
The health secretary has chipped away at the idea that immunizing children against measles and other diseases is a public ...
An advisory panel on vaccines meets, carefully, in the shadow of a health secretary who has often criticized it.
Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announced encouraging results in two preliminary ...
Complex Pandemic Accord negotiations have been under way since 2021, with 13 formal meetings and numerous informal sessions.
Shares in US biotech Novavax fell more than 20% before the weekend, following remarks from health and human services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results